Daily non-political popular news in brief.
Other highlights in the May 16 JNCI
05-15-2007 · EurekAlert!Also in the May 16 JNCI is a study linking moderate drinking and renal cell cancer, second cancers in childhood leukemia and lymphoma survivors, a study that finds no connection between clodronate and prostate cancer survival, and a protein that may prevent cancer cells from dying.
Read more »
Keywords: highlights, jnci, highlight
« Previous | Next »
Similar news on "Other highlights in the May 16 JNCI":
- Other highlights in the February 21 JNCI
02-20-2007 · EurekAlert!
Also in the February 21 JNCI are a new screening method for those at risk for a hereditary colorectal cancer, a mouse study of low-dose bisphosphonates' antitumor effects, and research on a protein that is active in metastasis suppression.
Similar news · Read more »
- Other highlights from the June 6 JNCI
06-05-2007 · EurekAlert!
Also in the June 6 JNCI is an association between aspirin use and decreased risk of cancer, a protein that suppresses tumor growth and cell migration, the incidence of a rare cancer in Denmark, and a protein that is not associated with inflammation, but not breast cancer.
Similar news · Read more »
- Other highlights in the April 4 JNCI
04-03-2007 · EurekAlert!
Also in the April 4 JNCI are a study on the risk of noncancer death among testicular cancer survivors, a report that celecoxib does not prevent cancer in Barrett's esophagus patients, and a link between bladder cancer and androgens in mice.
Similar news · Read more »
- Other highlights in the Oct. 30 JNCI
10-30-2007 · EurekAlert!
Also in the Oct. 30 JNCI -- a cancer-killing virus that may be used to treat metastatic cancer, the risk of second cancers in cervical cancer survivors, a novel trial design that shows which cancer treatments are the most promising, and a review on brain cancer therapies that target normal brain cells too.
Similar news · Read more »
- Other highlights in the Dec. 11 JNCI
12-11-2007 · EurekAlert!
Also in the Dec. 11 JNCI are a drug that may reduce breast cancer recurrence, the risk of cancer after a blood transfusion, the association between PSA testing and prostate cancer diagnoses, and cancer risk among NBN mutation carriers.
Similar news · Read more »
- Other highlights in the November 1 JNCI
10-31-2006 · EurekAlert!
Other highlights in the November 1 issue of JNCI include a review of statins and fibrates for action against melanoma, a study of a virus that kills brain tumors in mice, an antibody that decreases ovarian cancer growth in mice and a study that describes the use of the immunohistochemical assay in predicting clinical trial results for breast cancer patients.
Similar news · Read more »
- Other highlights in the May 2 JNCI
05-01-2007 · EurekAlert!
Also in the May 2 JNCI is a follow-up to the Italian Randomized Tamoxifen Trial, a study on treating breast cancer patients with three HER inhibitor drugs, an increase in survival rates for indolent lymphoma patients using a chemotherapy-rituximab combination, and new lung cancer risk prediction models.
Similar news · Read more »
- Other highlights from the July 10 JNCI
07-10-2007 · EurekAlert!
Also in the July 10 JNCI are studies on a "nanobubble" drug delivery method, a gene that may promote chemotherapy drug resistance, and an association between vitamin D and reduced colon cancer risk.
Similar news · Read more »
- Other highlights in the Jan. 29 JNCI
01-29-2008 · EurekAlert!
Also in the Jan. 29 JNCI are a protein associated with breast cancer prognosis, a study that refutes the idea that personality traits are linked to cancer, a study confirming the accuracy of pathology reports used in breast cancer trials, and an article demonstrating sorafinib’s potential for treating some leukemias.
Similar news · Read more »
- Other highlights in the March 7 JNCI
03-06-2007 · EurekAlert!
Other highlights in the March 7 JNCI include a study showing how changes in breast density affect breast cancer risk, a new potential treatment for prostate cancer, a gene that influences the formation of benign bone tumors, and an essay on the additional health benefits of breast cancer prevention drugs.
Similar news · Read more »
